Per Kogner

FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.

B. Agerberth, Hans Gunne, Jacob Odeberg et al. · Proceedings of the National Academy of Sciences · 1995 · 499 citations · Full text

Peptide Engineering, Molecular Biology, Antimicrobial Chemotherapy +20

The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation

Gaurav Kumar Pandey, Sanhita Mitra, Santhilal Subhash et al. · Cancer Cell · 2014 · 344 citations · Full text

Developmental Biology, Neuronal Differentiation, Cell Proliferation +6

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson et al. · The Lancet Oncology · 2017 · 334 citations · Full text

Oncology, Medicine, Versus Carboplatin +8

High incidence of DNA mutations and gene amplifications of the <i>ALK</i> gene in advanced sporadic neuroblastoma tumours

Helena Carén, Frida Abel, Per Kogner et al. · Biochemical Journal · 2008 · 272 citations · Full text

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

Helena Carén, Hanna Kryh, Maria Nethander et al. · Proceedings of the National Academy of Sciences · 2010 · 246 citations · Full text